🇺🇸 FDA
Pipeline program

Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method

261101

Approved mab completed

Quick answer

Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method for Hemophilia A is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Approved
Modality
mab
Status
completed

Clinical trials